Our results revealed no significant change in VEGF expression between the shLuc- and shKDELC2-transfected glioblastoma cells after NAC administration (Figure 2C), implying that KDELC2 inhibition could downregulate the angiogenic factor expression. The gene discussed is VEGFA; the disease is glioblastoma.